NCT06026332 2026-02-17
ABLE-41
Ferring Pharmaceuticals
Terminated
Clinical Trials
196 trialsNCT05555680 2025-12-09
HIP
Clinique Ovo
Terminated
NCT04967248 2025-12-04
A NIS of Alpelisib in Combination With Fulvestrant in Postmenopausal Women, and Men, With HR+,HER2- , Locally Advanced or Metastatic Breast Cancer With a PIK3CA Mutation, After Disease Progression Following Endocrine Therapy as Monotherapy, in the Real-world Setting
Novartis
Terminated
NCT05018338 2025-10-02
Brain-Shift Monitoring Using 3D Scanning
Advanced Scanners Inc.
Terminated
NCT01563796 2025-09-26
Efficacy Study of a Urine DEK ELISA for Diagnosis of Bladder Cancer
Medical Diagnostic Laboratories, LLC
Terminated
NCT05124743 2025-07-30
HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
Alaunos Therapeutics
Terminated
NCT05435352 2025-07-30
PEAR-TNBC
Ourotech, Inc.
Terminated
NCT06038760 2025-07-30
PEAR-GLIO
Ourotech, Inc.
Terminated
NCT06264479 2025-07-30
PEAR-TREE2
Ourotech, Inc.
Terminated
NCT05309733 2025-07-29
A Long-term Follow-up Study of Patients Who Received VOR33
Vor Biopharma
Terminated
NCT04125290 2025-07-18
PROXY
AstraZeneca
Terminated
NCT06655064 2025-07-14
Registry to Evaluate Long-Term Outcomes in Patients Who Undergo 68-Ga-PSMA-11 PET/CT Imaging Evaluations
Telix Pharmaceuticals (Innovations) Pty Limited
Terminated
NCT04107766 2025-07-08
NOLA (NeuWave Observational Liver Ablation) Registry
Ethicon, Inc.
Terminated
NCT01688011 2025-07-03
Connect® Myeloid Disease Registry
Celgene
Terminated
NCT05891197 2025-07-01
START
Lyell Immunopharma, Inc.
Terminated
NCT06421311 2025-06-05
URADJ
Bristol-Myers Squibb
Terminated
NCT06231693 2025-05-08
Trastuzumab-deruxtecan in Patients With Triple-negative Metastatic HER2-Low Breast Cancer: Real-world Experience in Brazil
AstraZeneca
Terminated
NCT05683678 2025-04-04
US Selumetinib Registry
Alexion Pharmaceuticals, Inc.
Terminated
NCT06375629 2025-04-02
ES-HIFU
EDAP TMS S.A.
Terminated
NCT04982471 2025-03-11
Connect® Lymphoma Disease Registry: A US-Based Prospective Observational Cohort Study
Celgene
Terminated
NCT02761187 2025-02-24
An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants
Takeda
Terminated
NCT03180853 2025-02-03
Multiple Myeloma Patient Registry
Janssen Scientific Affairs, LLC
Terminated
NCT03061305 2025-01-31
Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors
Strata Oncology
Terminated
NCT05615246 2025-01-27
HRP
Exactech
Terminated
NCT05534789 2025-01-20
Treatment Patterns and Clinical Outcomes Among Patients With Advanced Renal Cell Carcinoma (aRCC) Receiving Systemic First-line (1st Line) Anti-cancer Treatment Under Daily Routine in Germany: Retrospective Medical Chart Review (RENALISTIC Study).
Pfizer
Terminated
NCT03118037 2024-12-16
SAGE
Gynesonics
Terminated
NCT04142359 2024-12-10
PK Sub-Study of QUILT-3.032 (CA ALT-803-01-16) and of QUILT-2.005 (CA ALT-803-01-14)
Altor BioScience
Terminated
NCT03915717 2024-11-26
Observational Study of Outcomes After EchoMark and EchoSure-based Free Flap Monitoring
Sonavex, Inc.
Terminated
NCT05592483 2024-11-07
DB RESPOND
AstraZeneca
Terminated
NCT06068738 2024-09-26
EXCYTE-1
Exscientia AI Limited
Terminated
NCT05780736 2024-09-25
PROSPECT-ESO
Bristol-Myers Squibb
Terminated
NCT04753658 2024-09-23
Real World Data Collection Pediatric Neuroblastoma Treated With Lorlatinib
Pfizer
Terminated
NCT00151476 2024-09-04
Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Patients
Pfizer
Terminated
NCT03148093 2024-09-04
The CHOICE Registry
Taiho Oncology, Inc.
Terminated
NCT06126003 2024-08-02
Gut and Tumor Microbiome in Patients With Early Stage (II-III), Locally Advanced or Advanced ER-positive and HER2-negative Breast Cancer.
BioCorteX Inc
Terminated
NCT04545333 2024-08-01
The clonoSEQ® Watch Registry
Adaptive Biotechnologies
Terminated
NCT05068726 2024-07-31
Clinical Utility of FES F18 PET/CT in Metastatic Breast Cancer Patients
GE Healthcare
Terminated
NCT05645744 2024-07-22
Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product.
Mustang Bio
Terminated
NCT03777410 2024-07-03
Mass Accumulation Rate (MAR) as a Predictive Biomarker in Multiple Myeloma
Travera Inc
Terminated
NCT06288646 2024-05-31
Using Infrared Spectroscopy to Analyze Volatile Organic Compounds (VOCs) in the Breath of Patients With Lung Cancer
Breathe BioMedical Inc
Terminated
NCT03140176 2024-05-10
OPTIMISE
Pfizer
Terminated
NCT05699135 2024-04-24
TRAVELER
Pfizer
Terminated
NCT02455024 2024-04-04
OMNI
Takeda
Terminated
NCT04287075 2024-03-26
Rethink Pain
Axogen Corporation
Terminated
NCT04923802 2024-03-08
MOTIVATION
GeneCast Biotechnology Co., Ltd.
Terminated
NCT05922579 2024-02-29
A Study to Collect the Somatuline® Injector Device Preferences of Patients Living With Neuroendocrine Tumor (NET) and Nurses Involved in the Care of Patients With NET
Ipsen
Terminated
NCT02771795 2024-02-02
A Long-term Follow-up Study for Cardiac Safety in the Patients With HER2 (+) Breast Cancer Who Have Completed the SB3-G31-BC
Samsung Bioepis Co., Ltd.
Terminated
NCT01117779 2024-01-19
TRACE
Boston Scientific Corporation
Terminated
NCT04487405 2023-12-26
OVAnex
Aspira Women's Health
Terminated
NCT04668521 2023-12-26
OVA360
Aspira Women's Health
Terminated